Related Experiment Video
Updated: Feb 3, 2026

Single Liposome Measurements for the Study of Proton-Pumping Membrane Enzymes Using Electrochemistry and Fluorescent Microscopy
Published on: February 21, 2019
Proton-Pump Inhibitor Prophylaxis in the ICU - Benefits Worth the Risks?
1From the Division of Gastroenterology and Division of Clinical Epidemiology, McGill University Health Centre, Montreal General Hospital, McGill University, Montreal (A.B.); and Centre d'Investigation Clinique 1432 and Division of Gastroenterology, Centre Hospitalier Universitaire Dijon-Bourgogne, and Unité de Formation et de Recherche Sciences Santé, Université Bourgogne Franche Comté, Dijon, France (M.B.).
No abstract available in PubMed .
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Benefits of Self-Esteem
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
ATP Driven Pumps II: P-type Pumps
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
Relative Risk

